Description of Research Expertise
Contrast Media Injury to the Kidney
Cardiac – Renal Interactions
Selected Publications
Rudnick MR., Goldfarb S.: Pathogenesis of contrast-induced nephropathy: experimental and clinical observations with an emphasis on the role of osmolality. [Review] [31 refs] Reviews in Cardiovascular Medicine 4 Suppl 5 : S28-33,2003.
Wang A., Holcslaw T., Bashore TM., Freed MI., Miller D., Rudnick MR., Szerlip H., Thames MD., Davidson CJ., Shusterman N., Schwab SJ.: Exacerbation of radiocontrast nephrotoxicity by endothelin receptor antagonism.[see comment] Kidney International 57 (4): 1675-80,2000.
Berns JS., Rudnick MR., Cohen RM., Bower JD., Wood BC.: Effects of normal hematocrit on ambulatory blood pressure in epoetin-treated hemodialysis patients with cardiac disease Kidney International 56 (1): 253-60,1999.
Ermer JC., Boni JP., Cevallos WH., DeCleene S., Burghart P., Rudnick MR., Fruncillo RJ., Berns JS., Cohen RM.: Bromfenac disposition in patients with impaired kidney function Clinical Pharmacology & Therapeutics 61 (3): 312-8,1997.
Rudnick MR., Berns JS., Cohen RM., Goldfarb S.: Contrast media-associated nephrotoxicity. [Review] [150 refs] Seminars in Nephrology 17 (1): 15-26,1997.
Rudnick MR., Berns JS., Cohen RM., Goldfarb S.: Contrast media-associated nephrotoxicity. [Review] [83 refs] Current Opinion in Nephrology & Hypertension 5 (2): 127-33,1996.
Berns JS., Haghighat A., Staddon A., Cohen RM., Schmidt R., Fisher S., Rudnick MR., Tomaszewski JE.: Severe, irreversible renal failure after ifosfamide treatment. A clinicopathologic report of two patients Cancer 76 (3): 497-500,1995.
Rudnick MR., Goldfarb S., Wexler L., Ludbrook PA., Murphy MJ., Halpern EF., Hill JA., Winniford M., Cohen MB., VanFossen DB.: Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study Kidney International 47 (1): 254-61,1995.
Revicki DA., Brown RE., Feeny DH., Henry D., Teehan BP., Rudnick MR., Benz RL.: Health-related quality of life associated with recombinant human erythropoietin therapy for predialysis chronic renal disease patients American Journal of Kidney Diseases 25 (4): 548-54,1995.
Roth D., Smith RD., Schulman G., Steinman TI., Hatch FE., Rudnick MR., Sloand JA., Freedman BI., Williams WW Jr., Shadur CA., et al.: Effects of recombinant human erythropoietin on renal function in chronic renal failure predialysis patients American Journal of Kidney Diseases 24 (5): 777-84,1994.
Academic Contact Information
Presbyterian Medical Center
39th and Market Streets
Medical Office Building
Suite 240
Philadelphia,
Pa
19104
Phone: 215-662-8730
Patient appointments: 800-789-7366